Literature DB >> 3347813

[Intra-amniotic transmission of the human voice].

D Querleu1, X Renard, F Versyp, L Paris-Delrue, P Vervoort.   

Abstract

New acoustic measurements in amniotic environment permit to specify the conditions of transmission of human voices: voices emerge, incompletely covered by a low background noise, but however higher pitched near the placenta. The recognition of phonemes in utero is rather weak, approximately 30 per cent and appreciably identical for all voices and different mode of emission. Therefore this type of recognition is likely to play a minor role: the voices are evenly toneless by lack of high-pitch, and there is no obvious superiority of the intelligibility of direct maternal voice. The recognition of vowels by their second forming, as well as the emergence (demonstrated with special microphones) of impulse noises with very high-pitch components and of synthetic speech, confirm the possibility of transmission of frequencies exceeding 1,500 Hz to the intra-amniotic environment. On the contrary, melody recognition is excellent: probably major role of this factor. The loudness of the maternal voice transmitted to the uterus exceeds markedly that of outside voices, and this voice is certainly accessible to the fetus, most of the time. The demonstration of the transmission to the amniotic fluid of noises and voices enables to consider the possibility of perception.

Entities:  

Mesh:

Year:  1988        PMID: 3347813

Source DB:  PubMed          Journal:  Rev Fr Gynecol Obstet        ISSN: 0035-290X


  2 in total

Review 1.  An historical commentary on the physiological effects of music: Tomatis, Mozart and neuropsychology.

Authors:  B M Thompson; S R Andrews
Journal:  Integr Physiol Behav Sci       Date:  2000 Jul-Sep

2.  A melodic contour repeatedly experienced by human near-term fetuses elicits a profound cardiac reaction one month after birth.

Authors:  Carolyn Granier-Deferre; Sophie Bassereau; Aurélie Ribeiro; Anne-Yvonne Jacquet; Anthony J Decasper
Journal:  PLoS One       Date:  2011-02-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.